sign in sign up
<<
Home , Romifidine, Zilpaterol

Chapter 260-70 Chapter 260-70 WAC EQUINE PROGRAM

WAC 10-001, filed 4/17/96, effective 5/18/96. Statutory 260-70-500 Definitions applicable to chapter 260-70 WAC. Authority: RCW 67.16.040. 260-70-510 Equine health and safety. 260-70-028 Detention stall. [Statutory Authority: RCW 67.16.040. 260-70-540 Veterinarians' reports. WSR 93-23-008, § 260-70-028, filed 11/5/93, effective 260-70-545 Prohibited practices. 12/6/93. Statutory Authority: RCW 67.16.020 and 260-70-550 Medication labeling. 67.16.040. WSR 84-06-061 (Order 84-01), § 260-70- 260-70-560 Treatment restrictions. 028, filed 3/7/84.] Repealed by WSR 96-10-001, filed 260-70-570 All horses are subject to inspection. 4/17/96, effective 5/18/96. Statutory Authority: RCW 260-70-580 Official veterinarian's list. 67.16.040. 260-70-590 Reporting to the test barn. 260-70-029 Receiving barn. [Statutory Authority: RCW 67.16.020 260-70-600 Sample collection. and 67.16.040. WSR 84-06-061 (Order 84-01), § 260- 260-70-610 Storage and shipment of split samples. 70-029, filed 3/7/84.] Repealed by WSR 96-10-001, 260-70-620 Medication restrictions. filed 4/17/96, effective 5/18/96. Statutory Authority: 260-70-630 Threshold levels. RCW 67.16.040. 260-70-640 Permitted medication. 260-70-030 When administration prohibited. [Order 74.1, § 260-70- 260-70-645 Anti-ulcer . 030, filed 5/22/74, effective 7/1/74.] Repealed by WSR 260-70-650 Furosemide. 80-01-072 (Order 79-02), filed 12/24/79. Statutory 260-70-660 Furosemide and bleeder lists. Authority: RCW 67.16.020 and 67.16.040. 260-70-675 Bicarbonate testing. 260-70-031 Reporting to receiving barn. [Statutory Authority: RCW 260-70-680 Uniform classification guidelines. 67.16.020 and 67.16.040. WSR 84-06-061 (Order 84- 260-70-685 Alphabetical listing of all drugs, medications, and for- 01), § 260-70-031, filed 3/7/84.] Repealed by WSR 96- eign substances. 10-001, filed 4/17/96, effective 5/18/96. Statutory 260-70-710 Voiding track record. Authority: RCW 67.16.040. 260-70-720 Posterior digital neurectomy. 260-70-032 Exclusion from receiving and detention barn. [Statutory 260-70-730 Postmortem examination. Authority: RCW 67.16.020 and 67.16.040. WSR 84-06- 061 (Order 84-01), § 260-70-032, filed 3/7/84.] Repealed by WSR 96-10-001, filed 4/17/96, effective DISPOSITION OF SECTIONS FORMERLY 5/18/96. Statutory Authority: RCW 67.16.040. CODIFIED IN THIS CHAPTER 260-70-040 Horses to be tested. [Statutory Authority: RCW 67.16.- 040. WSR 94-04-002, § 260-70-040, filed 1/20/94, 260-70-010 Definitions applicable to chapter 260-70 WAC. [Statu- effective 2/20/94. Statutory Authority: RCW 67.16.020 tory Authority: RCW 67.16.020 and 67.16.040. WSR and 67.16.040. WSR 82-07-016 (Order 82-02), § 260- 89-04-026 (Order 88-06), § 260-70-010, filed 1/25/89; 70-040, filed 3/9/82; Order 74.1, § 260-70-040, filed WSR 87-15-020 (Resolution No. 87-03), § 260-70-010, 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- filed 7/8/87; WSR 86-09-072 (Order 86-02), § 260-70- 001, filed 4/17/96, effective 5/18/96. Statutory Author- 010, filed 4/21/86; WSR 84-06-061 (Order 84-01), § ity: RCW 67.16.040. 260-70-010, filed 3/7/84; Order 75.5, § 260-70-010, 260-70-050 Procedure for taking specimens. [Statutory Authority: filed 10/17/75; Order 74.1, § 260-70-010, filed 5/22/74, RCW 67.16.020 and 67.16.040. WSR 87-15-020 (Reso- effective 7/1/74.] Repealed by WSR 96-10-001, filed lution No. 87-03), § 260-70-050, filed 7/8/87. Statutory 4/17/96, effective 5/18/96. Statutory Authority: RCW Authority: RCW 67.16.020. WSR 78-06-001 (Order 78- 67.16.040. 1), § 260-70-050, filed 5/4/78; Order 74.1, § 260-70- 260-70-020 Medication permitted—Prohibited. [Statutory Author- 050, filed 5/22/74, effective 7/1/74.] Repealed by WSR ity: RCW 67.16.020. WSR 78-06-001 (Order 78-1), § 96-10-001, filed 4/17/96, effective 5/18/96. Statutory 260-70-020, filed 5/4/78; Order 74.1, § 260-70-020, Authority: RCW 67.16.040. filed 5/22/74, effective 7/1/74.] Repealed by WSR 80- 260-70-060 Effect of laboratory analysis. [Statutory Authority: 01-072 (Order 79-02), filed 12/24/79. Statutory Author- RCW 67.16.020. WSR 78-06-001 (Order 78-1), § 260- ity: RCW 67.16.020 and 67.16.040. 70-060, filed 5/4/78; Order 74.1, § 260-70-060, filed 260-70-021 Medication standards. [Statutory Authority: RCW 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- 67.16.020 and 67.16.040. WSR 87-15-020 (Resolution 001, filed 4/17/96, effective 5/18/96. Statutory Author- No. 87-03), § 260-70-021, filed 7/8/87; WSR 84-06-061 ity: RCW 67.16.040. (Order 84-01), § 260-70-021, filed 3/7/84; WSR 82-03- 260-70-070 Persons responsible. [Statutory Authority: RCW 67.16.- 053 (Order 82-01), § 260-70-021, filed 1/20/82; WSR 020. WSR 78-06-001 (Order 78-1), § 260-70-070, filed 80-01-072 (Order 79-02), § 260-70-021, filed 5/4/78; Order 74.1, § 260-70-070, filed 5/22/74, effec- 12/24/79.] Repealed by WSR 96-10-001, filed 4/17/96, tive 7/1/74.] Repealed by WSR 96-10-001, filed effective 5/18/96. Statutory Authority: RCW 67.16.040. 4/17/96, effective 5/18/96. Statutory Authority: RCW 260-70-025 Bleeder list. [Statutory Authority: RCW 67.16.040. 67.16.040. WSR 93-23-009, § 260-70-025, filed 11/5/93, effective 260-70-080 Procedure upon positive finding by chief chemist. [Stat- 12/6/93. Statutory Authority: RCW 67.16.020 and utory Authority: RCW 67.16.020. WSR 78-06-001 67.16.040. WSR 87-15-020 (Resolution No. 87-03), § (Order 78-1), § 260-70-080, filed 5/4/78; Order 74.1, § 260-70-025, filed 7/8/87; WSR 84-06-061 (Order 84- 260-70-080, filed 5/22/74, effective 7/1/74.] Repealed 01), § 260-70-025, filed 3/7/84.] Repealed by WSR 96- by WSR 96-10-001, filed 4/17/96, effective 5/18/96. 10-001, filed 4/17/96, effective 5/18/96. Statutory Statutory Authority: RCW 67.16.040. Authority: RCW 67.16.040. 260-70-090 Permitted level of approved NSAIDS. [Statutory 260-70-026 Bleeder treatment. [Statutory Authority: RCW 67.16.- Authority: RCW 67.16.020 and 67.16.040. WSR 89-04- 040. WSR 94-20-070, § 260-70-026, filed 10/3/94, 026 (Order 88-06), § 260-70-090, filed 1/25/89; WSR effective 11/3/94. Statutory Authority: RCW 67.16.020 87-15-020 (Resolution No. 87-03), § 260-70-090, filed and 67.16.040. WSR 87-15-020 (Resolution No. 87-03), 7/8/87; WSR 84-06-061 (Order 84-01), § 260-70-090, § 260-70-026, filed 7/8/87; WSR 84-06-061 (Order 84- filed 3/7/84; WSR 80-05-132 (Order 79-03), § 260-70- 01), § 260-70-026, filed 3/7/84.] Repealed by WSR 96- 090, filed 5/7/80; Order 74.1, § 260-70-090, filed 10-001, filed 4/17/96, effective 5/18/96. Statutory 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- Authority: RCW 67.16.040. 001, filed 4/17/96, effective 5/18/96. Statutory Author- 260-70-027 Reciprocity of bleeder list. [Statutory Authority: RCW ity: RCW 67.16.040. 67.16.020 and 67.16.040. WSR 84-06-061 (Order 84- 260-70-100 Penalties relating to overage of permitted medication. 01), § 260-70-027, filed 3/7/84.] Repealed by WSR 96- [Statutory Authority: RCW 67.16.020 and 67.16.040.

(4/11/16) [Ch. 260-70 WAC p. 1] 260-70-500 Equine Medication Program

WSR 85-12-057 (Order 85-02), § 260-70-100, filed 260-70-260 Adulteration of sample. [Order 74.1, § 260-70-260, filed 6/5/85; WSR 84-06-061 (Order 84-01), § 260-70-100, 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- filed 3/7/84; WSR 83-19-054 (Order 83-04), § 260-70- 001, filed 4/17/96, effective 5/18/96. Statutory Author- 100, filed 9/19/83; WSR 82-03-053 (Order 82-01), § ity: RCW 67.16.040. 260-70-100, filed 1/20/82; WSR 80-05-132 (Order 79- 260-70-270 Labelling of medications. [Order 74.1, § 260-70-270, 03), § 260-70-100, filed 5/7/80; Order 74.1, § 260-70- filed 5/22/74, effective 7/1/74.] Repealed by WSR 96- 100, filed 5/22/74, effective 7/1/74.] Repealed by WSR 10-001, filed 4/17/96, effective 5/18/96. Statutory 96-10-001, filed 4/17/96, effective 5/18/96. Statutory Authority: RCW 67.16.040. Authority: RCW 67.16.040. 260-70-280 Effective date—Repealer. [Order 74.1, § 260-70-280, 260-70-110 Commission may require association to set apart place filed 5/22/74, effective 7/1/74.] Repealed by WSR 96- for medication and testing. [Order 74.1, § 260-70-110, 10-001, filed 4/17/96, effective 5/18/96. Statutory filed 5/22/74, effective 7/1/74.] Repealed by WSR 96- Authority: RCW 67.16.040. 10-001, filed 4/17/96, effective 5/18/96. Statutory 260-70-290 Reporting to receiving barn. [Statutory Authority: RCW Authority: RCW 67.16.040. 67.16.020 and 67.16.040. WSR 82-09-016 (Order 82- 260-70-120 Sampling medications and drugs. [Statutory Authority: 03), § 260-70-290, filed 4/9/82.] Repealed by WSR 96- RCW 67.16.020 and 67.16.040. WSR 87-15-020 (Reso- 10-001, filed 4/17/96, effective 5/18/96. Statutory lution No. 87-03), § 260-70-120, filed 7/8/87; Order Authority: RCW 67.16.040. 74.1, § 260-70-120, filed 5/22/74, effective 7/1/74.] 260-70-300 Exclusion from receiving barn. [Statutory Authority: Repealed by WSR 96-10-001, filed 4/17/96, effective RCW 67.16.020 and 67.16.040. WSR 82-09-016 (Order 5/18/96. Statutory Authority: RCW 67.16.040. 82-03), § 260-70-300, filed 4/9/82.] Repealed by WSR 260-70-130 Voiding track record. [Order 74.1, § 260-70-130, filed 96-10-001, filed 4/17/96, effective 5/18/96. Statutory 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- Authority: RCW 67.16.040. 001, filed 4/17/96, effective 5/18/96. Statutory Author- 260-70-520 Trainer responsibility. [Statutory Authority: RCW ity: RCW 67.16.040. 67.16.020 and 67.16.040. WSR 06-09-009, § 260-70- 260-70-140 Hypodermic instruments. [Statutory Authority: RCW 520, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 67.16.020 and 67.16.040. WSR 81-09-075 (Order 81- 260-70-520, filed 3/11/05, effective 4/11/05. Statutory 03), § 260-70-140, filed 4/22/81; Order 74.1, § 260-70- Authority: RCW 67.16.040. WSR 96-10-001, § 260-70- 140, filed 5/22/74, effective 7/1/74.] Repealed by WSR 520, filed 4/17/96, effective 5/18/96.] Repealed by WSR 96-10-001, filed 4/17/96, effective 5/18/96. Statutory 07-03-065, filed 1/16/07, effective 2/16/07. Statutory Authority: RCW 67.16.040. Authority: RCW 67.16.020. 260-70-150 Who may administer medications. [Order 74.1, § 260- 260-70-530 Veterinarians under authority of official veterinarian. 70-150, filed 5/22/74, effective 7/1/74.] Repealed by [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 96-10-001, filed 4/17/96, effective 5/18/96. Statu- WSR 06-09-009, § 260-70-530, filed 4/10/06, effective tory Authority: RCW 67.16.040. 5/11/06; WSR 05-07-067, § 260-70-530, filed 3/11/05, 260-70-160 Veterinarians under the supervision of state veterinar- effective 4/11/05. Statutory Authority: RCW 67.16.040. ian—Test barn veterinarian. [Order 74.1, § 260-70-160, WSR 96-10-001, § 260-70-530, filed 4/17/96, effective filed 5/22/74, effective 7/1/74.] Repealed by WSR 96- 5/18/96.] Repealed by WSR 07-07-036, filed 3/12/07, 10-001, filed 4/17/96, effective 5/18/96. Statutory effective 4/12/07. Statutory Authority: RCW 67.16.020 Authority: RCW 67.16.040. and 67.16.040. 260-70-170 Veterinarian report. [Statutory Authority: RCW 67.16.- 260-70-670 Penalties—Guidelines. [Statutory Authority: RCW 020 and 67.16.040. WSR 87-15-020 (Resolution No. 67.16.040. WSR 96-10-001, § 260-70-670, filed 87-03), § 260-70-170, filed 7/8/87; WSR 80-05-132 4/17/96, effective 5/18/96.] Repealed by WSR 05-07- (Order 79-03), § 260-70-170, filed 5/7/80. Statutory 067, filed 3/11/05, effective 4/11/05. Statutory Author- Authority: RCW 67.16.020. WSR 78-06-001 (Order 78- ity: RCW 67.16.020 and 67.16.040. 1), § 260-70-170, filed 5/4/78; Order 74.1, § 296-70- 260-70-690 Penalty recommendations (in the absence of mitigating 170, filed 5/22/74, effective 7/1/74.] Repealed by WSR circumstances). [Statutory Authority: RCW 67.16.040. 96-10-001, filed 4/17/96, effective 5/18/96. Statutory WSR 96-10-001, § 260-70-690, filed 4/17/96, effective Authority: RCW 67.16.040. 5/18/96.] Repealed by WSR 05-07-067, filed 3/11/05, 260-70-180 Improper medication. [Order 74.1, § 260-70-180, filed effective 4/11/05. Statutory Authority: RCW 67.16.020 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- and 67.16.040. 001, filed 4/17/96, effective 5/18/96. Statutory Author- 260-70-700 Penalties relating to permitted medication. [Statutory ity: RCW 67.16.040. Authority: RCW 67.16.020. WSR 03-06-004, § 260-70- 260-70-190 Blocking of legs or ankles. [Order 74.1, § 260-70-190, 700, filed 2/20/03, effective 3/23/03. Statutory Author- filed 5/22/74, effective 7/1/74.] Repealed by WSR 96- ity: RCW 67.16.040. WSR 00-07-042, § 260-70-700, 10-001, filed 4/17/96, effective 5/18/96. Statutory filed 3/6/00, effective 4/6/00; WSR 96-10-001, § 260- Authority: RCW 67.16.040. 70-700, filed 4/17/96, effective 5/18/96.] Repealed by 260-70-200 Bandages. [Statutory Authority: RCW 67.16.020 and WSR 05-07-067, filed 3/11/05, effective 4/11/05. Statu- 67.16.040. WSR 82-09-016 (Order 82-03), § 260-70- tory Authority: RCW 67.16.020 and 67.16.040. 200, filed 4/9/82. Statutory Authority: RCW 67.16.020. WSR 78-06-001 (Order 78-1), § 260-70-200, filed 5/4/78; Order 74.1, § 260-70-200, filed 5/22/74, effec- WAC260-70-500 260-70-500 Definitions applicable to chapter tive 7/1/74.] Repealed by WSR 96-10-001, filed 260-70 WAC. (1) "Interfering substance" or "interfere" 4/17/96, effective 5/18/96. Statutory Authority: RCW 67.16.040. means and refers to any medication which might mask or 260-70-210 Nerving. [Order 74.1, § 260-70-210, filed 5/22/74, screen the presence of prohibited drugs or prevent testing effective 7/1/74.] Repealed by WSR 96-10-001, filed 4/17/96, effective 5/18/96. Statutory Authority: RCW procedures from detecting a prohibited drug. 67.16.040. (2) "Post time" means the time set for the arrival of the 260-70-220 Posterior digital neurectomy. [Order 74.1, § 260-70- horses at the starting point in a race as specified in writing 220, filed 5/22/74, effective 7/1/74.] Repealed by WSR 96-10-001, filed 4/17/96, effective 5/18/96. Statutory and posted by the board of stewards. Authority: RCW 67.16.040. [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § 260-70-230 List of nerved horses. [Order 74.1, § 260-70-230, filed 260-70-500, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- 001, filed 4/17/96, effective 5/18/96. Statutory Author- 500, filed 4/10/06, effective 5/11/06. Statutory Authority: RCW 67.16.040. ity: RCW 67.16.040. WSR 96-10-001, § 260-70-500, filed 4/17/96, effective 5/18/96.] 260-70-240 Examination required. [Order 74.1, § 260-70-240, filed 5/22/74, effective 7/1/74.] Repealed by WSR 96-10- 260-70-510 001, filed 4/17/96, effective 5/18/96. Statutory Author- WAC 260-70-510 Equine health and safety. The pur- ity: RCW 67.16.040. pose of this chapter is to protect the integrity of horse racing, 260-70-250 Medication procedures and related instructions. [Order to ensure the health and welfare of horses under the jurisdic- 74.1, § 260-70-250, filed 5/22/74, effective 7/1/74.] Repealed by WSR 96-10-001, filed 4/17/96, effective tion of the commission, and to safeguard the interests of the 5/18/96. Statutory Authority: RCW 67.16.040. public and the participants in racing. The commission will [Ch. 260-70 WAC p. 2] (4/11/16) Equine Medication Program 260-70-560 hold an annual public meeting, to review veterinarian prac- (4) Extracorporeal Shock Wave Therapy or Radial Pulse tices, equine health and medication. This meeting will Wave Therapy unless the following conditions are met: include: (a) Any treated horse may not race or workout for a min- (1) An annual report from an official veterinarian. imum of ten days following treatment; (2) Presentation of data regarding equine medication and (b) Extracorporeal Shock Wave Therapy or Radial Pulse treatment, including a review of the commission's quantita- Wave Therapy machines may only be used by veterinarians tive medication levels and any recommendations for modifi- licensed by the commission and only approved machines at a cations. previously disclosed location may be used; (3) Public comment regarding equine health and safety, (c) The practicing veterinarian has filed a report with an medication and veterinarian practices. official veterinarian notifying the commission that an Extra- [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § corporeal Shock Wave Therapy or Radial Pulse Wave Ther- 260-70-510, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- apy machine is on association grounds; 510, filed 4/10/06, effective 5/11/06. Statutory Authority: RCW 67.16.040. (d) All Extracorporeal Shock Wave Therapy or Radial WSR 96-10-001, § 260-70-510, filed 4/17/96, effective 5/18/96.] Pulse Wave Therapy treatments are reported to an official veterinarian on the prescribed form not later than twenty-four 260-70-540 WAC 260-70-540 Veterinarians' reports. (1) Every hours after treatment. veterinarian who treats a racehorse at any location under the The horse will be added to a list of ineligible horses. This jurisdiction of the commission must, on a form approved by list will be kept in the race office and be posted in an accessi- the commission, report all treatment to an official veterinar- ble location. ian. The report must include the following: (5) The use of a nasogastric tube (a tube longer than six (a) The name of the horse treated; inches) for the administration of any substance within (b) The name of any medication, drug, or substance twenty-four hours prior to the post time of the race in which administered or prescribed; the horse is entered and without the prior approval of an offi- (c) The procedure administered; cial veterinarian. (d) The name of the trainer; [Statutory Authority: RCW 67.16.020. WSR 13-03-061, § 260-70-545, filed (e) The date and time of treatment; and 1/11/13, effective 2/11/13. Statutory Authority: RCW 67.16.020 and 67.16.- (f) Any other information required by the official veteri- 040. WSR 07-07-036, § 260-70-545, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70-545, filed 4/10/06, effective 5/11/06; WSR 05-07-067, narian. § 260-70-545, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW (2) The practicing veterinarian must sign the report and 67.16.020. WSR 04-05-094, § 260-70-545, filed 2/18/04, effective 3/20/04.] file the report with an official veterinarian no later than post time of the race for which the horse is entered. If the horse is WAC260-70-550 260-70-550 Medication labeling. (1) No person, not entered to run in a race, the report must be filed with an excluding licensed veterinarians, may possess any drug, med- official veterinarian within forty-eight hours of treatment. ication, chemical, foreign substance or other substance unless (3) A timely and accurate treatment report may be con- the product is labeled as required by this rule. sidered by the stewards or the commission as a mitigating (2) Only medications and drugs prescribed or dispensed factor when determining the penalty for violation of these by a veterinarian licensed to practice veterinary medicine in rules. this jurisdiction may be on the grounds of a racing association [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § during its licensed race meet or training periods. All medica- 260-70-540, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- tions must have a prescription label attached with the follow- 540, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-540, filed ing: 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- 10-001, § 260-70-540, filed 4/17/96, effective 5/18/96.] (a) The name of the product; (b) The name, address and telephone number of the vet- WAC260-70-545 260-70-545 Prohibited practices. The following erinarian prescribing or dispensing the product; are prohibited practices: (c) The name of each horse (patient) the product is (1) The possession or use of any drug, substance, or intended/prescribed; medication if the use may endanger the health or welfare of (d) The dose, dosage, duration of treatment and expira- the horse or endanger the safety of the rider, or which may tion date of the prescribed/dispensed product; and adversely affect the integrity of racing; or (e) The name of the trainer or owner to whom the prod- (2) The possession or use of a drug or medication on the uct was dispensed. premises of a facility under the jurisdiction of the commis- [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § sion that has not been approved by the United States Food 260-70-550, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- 550, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-550, filed and Drug Administration (FDA) for any use in human or ani- 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- mal, or any substance forbidden by an official veterinarian. 10-001, § 260-70-550, filed 4/17/96, effective 5/18/96.] (3) The possession and/or use of blood doping agents including, but not limited to, those listed below, on the prem- WAC260-70-560 260-70-560 Treatment restrictions. (1) Except ises of a facility under the jurisdiction of the commission: as otherwise provided by this section, no person other than a (a) Erythropoietin; veterinarian licensed to practice veterinary medicine in this (b) Darbepoetin; jurisdiction and licensed by the commission may administer (c) Oxyglobin; and a prescription or controlled medication, drug, chemical or (d) Hemopure. other substance (including any medication, drug, chemical or (4/11/16) [Ch. 260-70 WAC p. 3] 260-70-570 Equine Medication Program other substance by injection) to a horse at any location under 570, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-570, filed the jurisdiction of the commission. 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- 10-001, § 260-70-570, filed 4/17/96, effective 5/18/96.] (2) Persons not licensed as veterinarians may administer the following substances, provided that, in post race testing 260-70-580 WAC 260-70-580 Official veterinarian's list. (1) An the substances do not exceed approved quantitative levels, official veterinarian will maintain a list of all horses deter- and the substances do not interfere with post race testing: mined by an official veterinarian to be unfit to compete in a (a) A recognized nutritional supplement or other sub- race due to illness, physical distress, unsoundness, infirmity stance, except that any such supplements or substances that or other medical condition. have been disapproved by an official veterinarian may not be (2) A horse may be removed from the veterinarian's list administered; when an official veterinarian determines the horse is capable (b) A substance given at the direction of or by a prescrip- of competing in a race. tion issued by a licensed veterinarian; or (a) Horses placed on the veterinarian's list that are (c) A nonprescription medication or substance. required to work prior to being removed from the list will (3) No person, other than a licensed veterinarian, may remain on the list for a minimum of seven days. (For pur- possess a hypodermic needle, syringe or device used for poses of counting days, the first day is the day the horse is intravenous or intramuscular injections on the grounds, placed on the veterinarian's list.) unless approved by the stewards. On all grounds under the (b) Horses that must work to be removed from the veter- jurisdiction of the commission, veterinarians may use only inary list due to soreness, lameness, or certain injuries will be onetime disposable needles, and shall dispose of them in a allowed to work no sooner than the eighth day after being manner approved by the department of health. placed on the list. (4) A person who has a medical condition requiring the (i) Works should be scheduled with an official veterinar- use of a hypodermic needle, syringe or other device used for ian twenty-four hours in advance. intravenous or intramuscular injections must possess a valid (ii) The official veterinarian may require a physical exam prescription issued by a physician licensed to practice medi- prior to approving the work. cine and prescribe medication. Such a person must control the storage and use of these devices and may be held account- (iii) Horses must work a minimum distance to be deter- able for any unauthorized use. Any person possessing a hypo- mined by an official veterinarian in a time comparable for the dermic needle or syringe without a valid prescription may be track condition that day. removed from the grounds. (iv) A blood test will be taken by an official veterinarian (5) Veterinarians may not treat or administer medication following the workout and medications levels may not or drugs to any horse on a race day before the post time for exceed permitted post-race levels. The horse may be allowed the race the horse is entered to run, except for the administra- to enter "conditionally" prior to the report from the testing tion of furosemide under the guidelines set forth in WAC laboratory. If the sample is reported to exceed a post-race 260-70-650, unless first approved by an official veterinarian. allowable threshold for an approved medication, the horse will be scratched. [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § (c) Horses placed on the veterinarian's list that are not 260-70-560, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- 560, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-560, filed required to work may not race for a minimum of thirteen days 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- from the date placed on the list. (For purposes of counting 10-001, § 260-70-560, filed 4/17/96, effective 5/18/96.] days, the first day is the day the horse is placed on the veteri- narian's list.) 260-70-570 WAC 260-70-570 All horses are subject to inspec- [Statutory Authority: RCW 67.16.020. WSR 15-17-068, § 260-70-580, filed tion. All horses at locations under the jurisdiction of the com- 8/15/15, effective 9/15/15; WSR 11-03-052, § 260-70-580, filed 1/14/11, mission are subject to inspections at the discretion of the effective 2/14/11. Statutory Authority: RCW 67.16.020 and 67.16.040. WSR stewards or an official veterinarian. 07-07-036, § 260-70-580, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70-580, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70- (1) The trainer of each horse or a representative of the 580, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. trainer must present the horse for inspection as required by an WSR 96-10-001, § 260-70-580, filed 4/17/96, effective 5/18/96.] official veterinarian. (2) The assessment of a horse's racing condition will be WAC260-70-590 260-70-590 Reporting to the test barn. (1) The based on the recommendations of the American Association official winning horse and any other horse ordered by the of Equine Practitioners and may include: stewards, official veterinarian or the commission must be (a) Proper identification of the horse; taken to the test barn to have a blood and/or urine sample (b) Observation of each horse in motion; taken at the direction of an official veterinarian. (c) Manual palpation when indicated; (2) Random or extra testing may be required by the stew- (d) Close observation in the paddock and saddling area, ards, an official veterinarian, or the commission at any time during the parade to post and at the starting gate; and on any horse on association grounds. (e) Any other inspection deemed necessary by an official (3) A horse selected for testing must be taken directly to veterinarian. the test barn, unless otherwise directed by the stewards or an (3) An official veterinarian will maintain a continuing official veterinarian. health and racing soundness record of each horse inspected. (4) Only persons currently licensed by the commission [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § may enter the test barn on a race day. Licensees must have a 260-70-570, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- valid reason for being in the test barn, and may be required to [Ch. 260-70 WAC p. 4] (4/11/16) Equine Medication Program 260-70-610 display their license. When accompanying a horse to the test (vi) A notation verifying that the lock was secured after barn no more than three licensees will be permitted to enter the freezer was closed. the test barn. (e) If at any time it is discovered that the split sample [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § freezer failed or samples were discovered not in a frozen con- 260-70-590, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- dition, an official veterinarian must document this discovery 590, filed 4/10/06, effective 5/11/06. Statutory Authority: RCW 67.16.040. on the split sample freezer log and immediately report this to WSR 96-10-001, § 260-70-590, filed 4/17/96, effective 5/18/96.] the executive secretary. (2) A trainer or owner of a horse having been notified 260-70-600 WAC 260-70-600 Sample collection. (1) Sample col- that a written report from a primary laboratory states that a lection shall be done in accordance with guidelines and substance has been found in a specimen obtained pursuant to instructions provided by official veterinarians. these rules may request that a split sample corresponding to (2) An official veterinarian shall determine a minimum the portion of the specimen tested by the primary laboratory sample requirement for the primary testing laboratory. be sent to another laboratory approved by the commission. (a) If the specimen obtained from a horse is less than the The request must be made in writing and delivered to the minimum sample requirement, the entire specimen shall be stewards not later than forty-eight hours after the trainer of sent to the primary testing laboratory. the horse receives written notice of the findings of the pri- (b) If a specimen obtained is greater than the minimum mary laboratory. The split sample must be shipped within sample requirement but less than twice that amount, the por- seventy-two hours of the delivery of the request for testing to tion of the sample that is greater than the minimum sample the stewards. requirement shall be secured as the split sample. (3) The owner or trainer requesting testing of a split sam- (c) If a specimen obtained is greater than twice the mini- ple is responsible for the cost of shipping and testing. A split mum sample requirement, a portion of the sample approxi- sample must be removed from the split sample freezer, and mately equal to the amount provided for the primary testing packaged for shipment by an official veterinarian or designee laboratory shall be secured as the split sample. in the presence of the owner, trainer, or designee. Failure of (d) Blood samples must be collected at a consistent time, the owner, trainer or designee to appear at the time and place preferably not later than one hour post-race. designated by an official veterinarian to package the split (e) At Class C race tracks the splitting of samples will be sample for shipping will constitute a waiver of all rights to conducted by the primary testing laboratory. split sample testing. Prior to shipment, the split sample labo- [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 05-07-067, § ratory's willingness to provide the testing requested and to 260-70-600, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW send results to both the person requesting the testing and the 67.16.040. WSR 96-10-001, § 260-70-600, filed 4/17/96, effective 5/18/96.] commission, must be confirmed by an official veterinarian. Arrangements for payment satisfactory to the split sample WAC260-70-610 260-70-610 Storage and shipment of split sam- laboratory must also be confirmed by the owner or trainer. A ples. (1) Split samples obtained in accordance with WAC laboratory for the testing of a split sample must be approved 260-70-600 (2)(b) and (c) will be secured and made available by the commission. The commission will maintain a list of for further testing in accordance with the following proce- laboratories approved for testing of split samples. dures: (4) Prior to opening the split sample freezer, the commis- (a) A split sample must be secured in the test barn in the sion must provide a split sample chain of custody verification same manner as the primary sample acquired for shipment to form. The split sample chain of custody verification form a primary laboratory. The split samples will be stored until must be completed and signed by the representatives of the the primary samples are packed and secured for shipment to commission and the owner, trainer or designee. A commis- the primary laboratory. Split samples will then be transferred sion representative will keep the original and provide a copy to a freezer at a secure location approved by the executive to the owner, trainer or designee. secretary. The split sample chain of custody verification form must (b) A freezer used to store split samples will be closed include the following: and locked at all times except as specifically provided by (a) The date and time the sample is removed from the these rules. split sample freezer; (c) A freezer for storage of split samples may only be (b) The sample number; opened to deposit or remove split samples, for inventory, or (c) The address where the split sample is to be sent; for checking the condition of samples. (d) The name of the carrier and the address where the (d) An official veterinarian will maintain a split sample sample is to be taken for shipment; log that must be used each time a split sample freezer is (e) Verification of retrieval of the split sample from the opened. The log will record the following: freezer; (i) The name of the person opening the split sample (f) Verification of each specific step of the split sample freezer; packaging in accordance with the recommended procedure; (ii) The purpose for opening the freezer; (g) Verification of the address of the split sample labora- (iii) The split samples deposited or removed from the tory on the split sample package; freezer; (h) Verification of the condition of the split sample pack- (iv) The date and time the freezer was opened; age immediately prior to transfer of custody to the carrier; (v) The time the freezer was closed; and and (4/11/16) [Ch. 260-70 WAC p. 5] 260-70-620 Equine Medication Program

(i) The date and time custody of the sample is transferred Mepivacaine - 10 ng/ml to the carrier. Omeprozole - 1 ng/ml (j) The split sample chain of custody verification form - 25 ng/ml must be signed by both the owner's representative and an offi- Pyrilamine - 25 ng/ml cial veterinarian or designee to confirm the packaging of the split sample. (b) The following quantitative medications and/or (5) The exterior of the package must be secured and metabolites are permissible in test samples up to the stated identified with initialed tape, evidence tape or other means to concentrations in serum or plasma: prevent tampering with the package. The owner, trainer or Betamethasone - 10 pg/ml designee may inspect the package containing the split sample - 2 ng/ml immediately prior to transfer to the delivery carrier to verify that the package is intact and has not been tampered with. - 25 pg/ml (6) The package containing the split sample will be Dantrolene - 100 pg/ml transported to the location where custody is transferred to the Dexamethasone - 1 ng/ml delivery carrier charged with delivery of the package to the Diclofenac - 5 ng/ml commission approved laboratory selected by the owner or DMSO - 10 mc/ml trainer. Firocoxib - 40 ng/ml [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § Glycopryrrolate - 3 pg/ml 260-70-610, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- Isoflupredone - 100 pg/ml 610, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-610, filed Lidocaine - 20 pg/ml 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.020. WSR 03- 11-018, § 260-70-610, filed 5/12/03, effective 6/12/03. Statutory Authority: - 1 ng/ml RCW 67.16.040. WSR 96-10-001, § 260-70-610, filed 4/17/96, effective Methylprednisolone - 1.3 ng/ml 5/18/96.] Prednisolone - 1 ng/ml *Procaine penicillin - 25 ng/ml 260-70-620 WAC 260-70-620 Medication restrictions. (1) A find- Triamcinolone - 100 pg/ml ing by the commission approved laboratory of a prohibited - 0.2 ng/ml drug, chemical or other substance in a test specimen of a horse is prima facie evidence that the prohibited drug, chem- * Administration of procaine penicillin to those horses entered must be reported to the commission and may require surveil- ical or other substance was administered to the horse and, in lance up to six hours prior to post time. the case of a post-race test, was present in the horse's body while it was participating in a race. Prohibited substances (c) The official urine or blood test sample may not con- include: tain more than one of the above substances, including their (a) Drugs or medications for which no acceptable thresh- metabolites or analogs, and may not exceed the concentra- old concentration has been established; tions established in this rule. (b) Therapeutic medications in excess of established (2) Environmental substances. threshold concentrations; (a) Certain substances can be considered "environmen- (c) Substances present in the horse in excess of concen- tal" in that they are endogenous to the horse or that they can trations at which such substances could occur naturally; and arise from plants traditionally grazed or harvested as equine (d) Substances foreign to a horse at concentrations that feed or are present in equine feed because of contamination cause interference with testing procedures. or exposure during the cultivation, processing, treatment, (2) Except as otherwise provided by this chapter, a per- storage, or transportation phases. Certain drugs are recog- son may not administer or cause to be administered to a horse nized as substances of human use and could therefore be by any means, a prohibited drug, medication, chemical or found in a horse. The following substances are permissible in other substance, including any restricted medication pursuant test samples up to the stated concentrations: to this chapter during the twenty-four hour period before post Arsenic - 0.3 mc/ml urine time for the race in which the horse is entered. Caffeine - 100 ng/ml serum or plasma [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 06-09-009, § Benzoylecgonine - 50 ng/ml urine 260-70-620, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70- 620, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. Estranediol - 0.045 mc/ml free + conjugated (5a-oes- WSR 96-10-001, § 260-70-620, filed 4/17/96, effective 5/18/96.] trane-3β,17a-diol), in male horses, other than geldings Hydrocortisone - 1 mc/ml urine WAC260-70-630 260-70-630 Threshold levels. (1) Permitted Methoxytyramine - 4 mc/ml, free + conjugated urine medications. Glucuronides - 50 ng/ml urine (a) The following quantitative medications and/or Salicylate saliclic acid - 750 mc/ml serum or plasma metabolites are permissible in test samples up to the stated Theobromine - 2 mc/ml urine concentrations in urine: (b) If a preponderance of evidence presented shows that Acepromazine - 25 ng/ml a positive test is the result of environmental substance or Albuterol - 1 ng/ml inadvertent exposure due to human drug use, that evidence Bupivicaine - 5 ng/ml should be considered as a mitigating factor in any disci- - 1 ng/ml plinary action taken against the trainer. [Ch. 260-70 WAC p. 6] (4/11/16) Equine Medication Program 260-70-650

(3) Androgenic-anabolic steroids. titative NSAID level(s) and/or the presence of other drugs (a) The following androgenic-anabolic steroids are per- which may be present in the blood or urine sample(s). missible in test samples up to the stated concentrations: [Statutory Authority: RCW 67.16.020. WSR 16-09-015, § 260-70-640, filed 4/11/16, effective 5/12/16; WSR 12-07-005, § 260-70-640, filed 3/9/12, Boldenone (Equipoise) - 15 ng/ml urine in intact males. effective 4/9/12. Statutory Authority: RCW 67.16.020 and 67.16.040. WSR No level is permitted in geldings, fillies or mares. 08-09-044, § 260-70-640, filed 4/10/08, effective 5/11/08; WSR 07-07-036, Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fil- § 260-70-640, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- 640, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-640, filed lies, and mares, and for nandrolone metabolite (5a-oestrane- 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- 3β,17a-diol) - 45 ng/ml urine in intact males. 10-001, § 260-70-640, filed 4/17/96, effective 5/18/96.] Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be WAC260-70-645 260-70-645 Anti-ulcer medications. The fol- tested for the presence of testosterone. lowing anti-ulcer medications are permitted to be adminis- (b) All other androgenic-anabolic steroids are prohibited tered, at the stated dosage, up to twenty-four hours prior to in race horses. the race in which the horse is entered. (1) Cimetidine (Tagamet®) - 8-20 mg/kg PO BID - TID [Statutory Authority: RCW 67.16.020. WSR 15-13-079, § 260-70-630, filed 6/12/15, effective 7/13/15; WSR 14-13-074, § 260-70-630, filed 6/13/14, (2) Omeprazole (Gastrogard®) - 2.2 grams PO SID effective 7/14/14; WSR 13-07-045, § 260-70-630, filed 3/15/13, effective (3) Ranitidine (Zantac®) - 8 mg/kg PO BID 4/15/13; WSR 12-07-010, § 260-70-630, filed 3/9/12, effective 4/9/12. Stat- utory Authority: RCW 67.16.020 and 67.16.040. WSR 08-17-051, § 260-70- [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 06-09-009, § 630, filed 8/14/08, effective 9/14/08; WSR 08-05-091, § 260-70-630, filed 260-70-645, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70- 2/15/08, effective 6/1/08; WSR 06-09-009, § 260-70-630, filed 4/10/06, 645, filed 3/11/05, effective 4/11/05.] effective 5/11/06; WSR 05-07-067, § 260-70-630, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.020. WSR 04-05-095, § 260-70- WAC260-70-650 260-70-650 Furosemide. (1) Furosemide may be 630, filed 2/18/04, effective 3/20/04; WSR 03-11-019, § 260-70-630, filed 5/12/03, effective 6/12/03. Statutory Authority: RCW 67.16.040. WSR 96- administered intravenously to a horse which is entered to 10-001, § 260-70-630, filed 4/17/96, effective 5/18/96.] compete in a race. Except under the instructions of an official veterinarian for the purpose of removing a horse from the vet- WAC260-70-640 260-70-640 Permitted medication. Trainers erinarian's list or to facilitate the collection of a urine sample, using permitted medication in the care of their horses are sub- furosemide will be permitted only after an official veterinar- ject to all rules governing such medications. Failure to ian has placed the horse on the furosemide or bleeder list. administer permitted medication to a horse on a program of (2) The use of furosemide is permitted under the follow- permitted medication is a violation of these rules. ing circumstances: (1) The use of one of three approved nonsteroidal anti- (a) Furosemide must be administered on the grounds of inflammatory drugs (NSAIDs) is permitted under the follow- the association, by a single intravenous injection. Adminis- ing conditions: tration of furosemide must be no later than three hours prior (a) The drug may not exceed the following permitted to post time for the race for which the horse is entered without serum or plasma threshold concentrations, which are consis- prior approval of a regulatory veterinarian. tent with administration by a single intravenous injection at (b) The furosemide dosage administered must not least twenty-four hours before the post time for the race in exceed 500 mg nor be less than 150 mg. which the horse is entered: (c) The trainer of the treated horse must deliver to an (i) Phenylbutazone - 5 micrograms per milliliter in over- official veterinarian or his/her designee no later than one hour night and nongraded stakes races, and 2 micrograms per mil- prior to post time for the race for which the horse is entered liliter in graded stakes races; the following information under oath on a form provided by (ii) Flunixin - 50 nanograms per milliliter; the commission: (iii) Ketoprofen - 10 nanograms per milliliter. (i) The name of the horse, the horse's tattoo number, (b) No NSAID, including the approved NSAIDs listed in racetrack name, the date and time the furosemide was admin- this rule, may be administered within the twenty-four hours istered to the entered horse; before post time for the race in which the horse is entered. (ii) The dosage amount of furosemide administered to (c) The presence of a second approved NSAID will not the entered horse; be considered a violation if the approved NSAID is not over (iii) The printed name and signature of the attending the secondary threshold as follows: licensed veterinarian who administered the furosemide; and (i) Phenylbutazone - 1 mcg per milliliter; (iv) The signature of the trainer or his/her representative. (ii) Flunixin - 3 ng per milliliter; (d) Failure to administer furosemide in accordance with (iii) Ketoprofen - 1 ng per milliliter. these rules may result in the horse being scratched from the (d) Any unapproved NSAID in the post-race serum or race by the stewards. plasma sample is not permitted. The use of all but one of the (e) Test results must show a detectable concentration of approved NSAIDs must be discontinued at least forty-eight the drug in the post-race serum, plasma or urine sample. hours before the post time for the race in which the horse is (i) The specific gravity of post-race urine samples may entered. be measured to ensure that samples are sufficiently concen- (2) Any horse to which a NSAID has been administered trated for proper chemical analysis. The specific gravity must is subject to having a blood and/or urine sample(s) taken at not be below 1.010. If the specific gravity of the urine is the direction of an official veterinarian to determine the quan- found to be below 1.010 or if a urine sample is unavailable (4/11/16) [Ch. 260-70 WAC p. 7] 260-70-660 Equine Medication Program for testing, quantitation of furosemide in serum or plasma nostrils during or after a race or workout as observed by an will be performed; official veterinarian. (ii) Quantitation of furosemide in serum or plasma must (b) Following an incident of bleeding that is confirmed be performed when the specific gravity of the corresponding to be as a result of exercise induced pulmonary hemorrhage, urine sample is not measured or if measured below 1.010. the horse, regardless of age, must be placed on the bleeder list Concentrations may not exceed 100 nanograms of furose- and is ineligible to race for the following time periods: mide per milliliter of serum or plasma. (i) First incident - fourteen days; [Statutory Authority: RCW 67.16.020. WSR 16-09-017, § 260-70-650, filed (ii) Second incident within three hundred and sixty-five 4/11/16, effective 5/12/16. Statutory Authority: RCW 67.16.020 and 67.16.- day period - thirty days; 040. WSR 07-07-036, § 260-70-650, filed 3/12/07, effective 4/12/07; WSR (iii) Third incident within three hundred and sixty-five 06-09-009, § 260-70-650, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-650, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW day period - one hundred and eighty days; 67.16.020. WSR 03-06-004, § 260-70-650, filed 2/20/03, effective 3/23/03. (iv) Fourth incident within three hundred and sixty-five Statutory Authority: RCW 67.16.040. WSR 02-10-102, § 260-70-650, filed day period - barred from racing for life. 4/30/02, effective 5/31/02; WSR 96-10-001, § 260-70-650, filed 4/17/96, effective 5/18/96.] (c) For the purposes of counting the number of days a horse is ineligible to run, the day the horse bled externally is WAC260-70-660 260-70-660 Furosemide and bleeder lists. The the first day of the ineligibility period. official veterinarians will maintain a furosemide list and a (d) The voluntary administration of furosemide without bleeder list of all horses eligible to race with furosemide. The an external bleeding incident will not subject the horse to the list is a statewide list that applies to all licensed associations. initial period of ineligibility as defined by this policy. (1) Furosemide list. (e) Every horse that is confirmed a bleeder will have a (a) A horse is eligible to race with furosemide if the notation affixed to the horse's certificate of registration. licensed trainer and/or veterinarian determine that it would be (f) A horse may be removed from the bleeder list only in the horse's best interests to race with furosemide. Notifica- upon the direction of an official veterinarian. tion using prescribed commission forms must be given to an (3) A horse which has been placed on a furosemide or official veterinarian prior to the close of entries to ensure bleeder list in another jurisdiction may be placed on the furo- public notification. semide list in this jurisdiction. (b) If an official veterinarian so orders, a horse placed on [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § the furosemide list will be placed in detention in its regularly 260-70-660, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- 660, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-660, filed assigned stall, no later than four hours prior to the scheduled 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.020. WSR 03- post time for any race in which it is entered to start, and with 06-004, § 260-70-660, filed 2/20/03, effective 3/23/03. Statutory Authority: oral or written notification to the trainer may be watched by RCW 67.16.040. WSR 96-10-001, § 260-70-660, filed 4/17/96, effective commission staff. Once placed in detention, a horse must 5/18/96.] remain in its barn or on its assigned hotwalker until it is taken to the receiving barn or to the paddock to be saddled for the WAC260-70-675 260-70-675 Bicarbonate testing. No bicarbon- race, except that the stewards may permit a horse to leave ate-containing substance or alkalizing substance that effec- detention to engage in exercise blowouts or warm-up heats. tively alters the serum or plasma pH or concentration of (c) The confirmation of a horse eligible to race with furo- bicarbonates or total carbon dioxide in a horse may be admin- semide must be certified in writing by an official veterinarian istered to a horse within twenty-four hours of post time of the and entered on the furosemide list. Copies of the certification race in which the horse is entered. will be issued to the owner of the horse or the owner's desig- An official veterinarian, the board of stewards or the nee upon request. executive secretary acting on behalf of the commission may (d) Every horse eligible to race with furosemide, regard- at their discretion and at any time order the collection of test less of age, will be placed on the furosemide list. samples from any horses either in the horse's stall or within (e) A horse placed on the official furosemide list must the receiving or test barn to determine the serum or plasma remain on that list unless the licensed trainer and/or veteri- pH or concentration of bicarbonate, total carbon dioxide, or narian submit(s) a written request to remove the horse from electrolytes. the list. The request must be on commissioned-approved Test samples must not exceed 37.0 millimoles of total forms and must be submitted to an official veterinarian no carbon dioxide concentration per liter of serum or plasma. A later than time of entry. After a horse has been removed from serum or plasma total carbon dioxide level exceeding this the furosemide list, the horse may not be placed back on the value is a violation of this rule. Penalties will be assessed as a list for a period of sixty calendar days unless determined to be Class 4 violation as provided in WAC 260-84-110(6). detrimental to the welfare of the horse, in consultation with Split samples will be taken from all horses entered to run an official veterinarian. If a horse is removed from the offi- in a race when bicarbonate testing is to be done. When split cial furosemide list a second time in a three hundred sixty- samples are taken, they will be shipped as soon as practical to five day period, the horse may not be placed back on the list the commission-approved laboratories for total carbon diox- for a period of ninety calendar days. ide split sample testing. The commission is responsible for (2) Bleeder list. the cost of shipping and testing of split samples taken under (a) An official veterinarian will maintain a bleeder list of this section. all horses, which have demonstrated external evidence of [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § exercise induced pulmonary hemorrhage from one or both 260-70-675, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- [Ch. 260-70 WAC p. 8] (4/11/16) Equine Medication Program 260-70-685

675, filed 4/10/06, effective 5/11/06; WSR 05-17-123, § 260-70-675, filed (4) Class 4 8/18/05, effective 9/18/05.] Class 4 drugs include therapeutic drugs/medications/for- eign substances that would be expected to have less potential 260-70-680 WAC 260-70-680 Uniform classification guidelines. to affect the performance of a racing horse than class 3 drugs. This section classifies drugs, medications, and foreign sub- (5) Class 5 stances. The names, trade names, classifications, and if appli- Class 5 drugs include those therapeutic medications for cable a reference to the section containing the permitted which concentration limits have generally been established threshold are listed alphabetically in WAC 260-70-685. The by racing jurisdictions as well as certain miscellaneous penalties for violation of this section are in WAC 260-84- agents and other medications. Included are specifically 110. agents that have very localized actions only, such as anti- (1) Class 1 ulcer drugs and certain anti-allergic drugs. The anticoagulant Class 1 drugs are stimulant and drugs that drugs are also included. have the highest potential to affect the performance of a (6) Nonclassified substances horse, and have no generally accepted medical use. Many of Nonclassified substances are considered to have no these agents are Drug Enforcement Agency (DEA) Schedule effect on the physiology of a horse, except to improve nutri- II substances. These include the following drugs and their tion or treat or prevent infections or parasite infestations. metabolites: Opiates, opium derivatives, synthetic These substances normally include antimicrobials, antipara- and psychoactive drugs, amphetamines and amphetamine- sitic drugs, and nutrients such as vitamins. like drugs as well as related drugs, including but not limited (7) Substances denoted with a "*" are medications that to , nikethamide, mazindol, pemoline, and pen- are currently being studied at a national level to establish tylenetetrazol. thresholds, currently have an established threshold, or could (2) Class 2 be considered an environmental contaminate based on the Class 2 drugs are drugs/medication/foreign substances level reported. In the instance of a positive reported for these that have a high potential to affect the performance of a horse, medications the stewards may use this as mitigating circum- but less of a potential than class 1 drugs. Class 2 drugs are stances, taking into account the level reported, when ruling either not generally accepted as therapeutic agents in racing on the violation. horses, or are therapeutic agents that have a high potential for [Statutory Authority: RCW 67.16.020. WSR 15-07-058, § 260-70-680, filed abuse. 3/16/15, effective 4/16/15; WSR 12-07-006, § 260-70-680, filed 3/9/12, (3) Class 3 effective 4/9/12. Statutory Authority: RCW 67.16.020 and 67.16.040. WSR Class 3 drugs are drugs/medication/foreign substances 08-03-046, § 260-70-680, filed 1/10/08, effective 2/10/08; WSR 07-07-012, that may or may not have generally accepted medical use in § 260-70-680, filed 3/8/07, effective 4/8/07; WSR 06-09-009, § 260-70-680, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-680, filed the racing horse, but the pharmacology of which suggests less 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- potential to affect performance than class 2 drugs. 10-001, § 260-70-680, filed 4/17/96, effective 5/18/96.]

WAC260-70-685 260-70-685 Alphabetical listing of all drugs, medications, and foreign substances. This section contains an alphabetical listing of all drugs, medications and foreign substances classified in WAC 260-70-680.

Drug Trade Name Class Penalty Class Sectral 3 A 2 A Acenocoumarol 5 C *Acepromazine Atrovet, Notensil, PromAce© 3 B Acetaminophen (Phenacetin) Tylenol, Tempra, etc. 4 C Acetanilid 4 B Acetazolamide Diamox, Vetamos 4 B Tindal 2 A Acetophenetidin (Phenacetin) 4 B Acetylsalicylic acid (Aspirin) 4 C Aclomethasone Aclovate 4 C Adinazolam 2 A Adrenochrome monoremicarbazone salicylate 4 B *Albuterol () Proventil Ventolin 3 B Alclofenac 2 A Alcuronium Alloferin 2 A Aldosterone Aldocortin, Electrocortin 4 B

(4/11/16) [Ch. 260-70 WAC p. 9] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Alfentanil Alfenta 1 A Almotriptan Axert 3 A Alphaprodine Nisentil 2 A Alpidem Anaxyl 2 A Alprazolam Xanax 2 A 3 A Althesin Saffan 2 A Ambenonium Mytelase, Myeuran 3 B Ambroxol Ambril, etc. 4 C Amcinonide Cyclocort 4 C Amiloride Moduretic; Midamor 4 B Aminocaproic acid Amicar, Caprocid 4 C Aminodarone 4 B 2-Aminoheptaine Tuamine 4 B Aminophylline Aminophyllin, etc. 3 B Aminopyrine 4 B Aminorex Aminoxafen, Aminoxaphen, 1 A Apiquel, McN-742, Menocil Amisometradine Rolictron 4 B Amisulpride Solian 2 A Mitaban 3 A Elavil, Amitril, Endep 2 A Amlopidine Norvasc, Ammivin 4 B Amytal 2 A Asendin 2 A Amperozide 2 A Amphetamine 1 A Amrinone 4 B Amyl nitrite 3 A Anileridine Leritine 1 A Anilopam Anisine 2 A Anisindione 5 C Anisotropine Valpin 4 B Antipyrine 4 B Apazone (Azapropazone) Rheumox 4 B Apomorphine 1 A Aprindine 4 B Alurate 2 A Arecoline 3 A 3 A Articaine Septocaine; Ultracaine, etc. 2 A Tenormin 3 B Atomoxetine Strattera 2 A Atracurium Tracrium 2 A

[Ch. 260-70 WAC p. 10] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Atropine 3 B Azacylonol Frenque 2 A Azaperone Stresnil, Suicalm, Fentaz (with 2 A Fentanyl) Lioresal 4 B Veronal 2 A 2 A Beclomethasone Propaderm 4 C Bemegride Megimide, Mikedimide 2 A Benazeprilat, Benazepril and MC-tab Lotrel, Lotensin 3 A Bendroflumethiazide Naturetin 4 B Benoxaprofen 2 A Benoxinate Dorascaine 4 C Benperidol Anquil 2 A Bentazepam Tiadipona 2 A Benzactizine Deprol, Bronchodiletten 2 A Benzocaine 4 B 2 A 2 A Benzonatate Tessalon, Tessalon Perles, Zona- 2 A tuss Benzphetamine Didrex 2 A Benzthiazide 4 B Benztropine Cogentin 2 A (BZP) 1 A Bepridil Bepadin 4 B *Betamethasone Betasone, etc. 4 C Kerlone 3 B Bethanechol Uriecholine, Duviod 4 C Bethanidine Esbatal 3 A Biperiden Akineton 3 A Biriperone 2 A Zebeta, Bisobloc, etc. 3 B Effectin 3 A Bolasterone 3 A *Boldenone Equipose 3 B Boldione 3 A Bretylium Bretylol 3 B Alphagan 2 A Bromazepam Lexotan, Lectopam 2 A Bromfenac Duract 3 A Bromhexine Oletor, etc. 4 B Bromisovalum Diffucord, etc. 2 A Parlodel 2 A

(4/11/16) [Ch. 260-70 WAC p. 11] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Bromodiphenhydramine 3 B Bromperidol Bromidol 2 A Brompheniramine Diemtane, Disomer 4 B Brotocol 2 A Budesonide Pulmacort, Rhinocort 4 C Bufexamac 3 A Bumetanide Bumex 3 B *Bupivacaine Marcaine 2 A Buprenorphine Temgesic 2 A Bupropion Wellbutrin 2 A Buspar 2 A (Secbutobarbitone) Butacaps, Butasol, etc. 2 A Butacaine Butyn 4 B Butalbital () Fiorinal 2 A Butamben (butylaminobenzoate) Butesin 4 C Butanilicaine Hostacain 2 A Repoise 2 A Butoctamide Listomin 2 A *Butorphanol Stadol, Torbugesic 3 B Butoxycaine Stadacain 4 B N-Butylscopolamine 3 B *Caffeine 2 B Calusterone 3 B Camazepam Paxor 2 A Camphor 4 C Candesartan Atacand 3 B Covatine 2 A Captopril Capolen 3 B Carbacel, Conducton 3 A Carbachol Lentin, Doryl 3 B Carbamezapine Tegretol 3 B Carbazochrome 4 C Carbidopa + levodopa Sinemet 2 A Carbinoxamine Clistin 3 B Carbromol Mifudorm 2 A Carfentanil 1 A Soma, Rela 2 B Carphenazine Proketazine 2 A Prazinil 2 A Carprofen Rimadyl 4 B Cartrol 3 B Carticaine (see Articaine) Septocaine; Ultracaine, etc. 2 A Coreg 3 B

[Ch. 260-70 WAC p. 12] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Cathinone khat, kat, qat, quat, chat, atha, 1 A Abyssinian tea, African tea Celecoxib Celebrex 3 B Cetirizine Zyrtec 4 B Beta-Chlor 2 A Nactec, Oridrate, etc. 2 A Chloradldehyde (chloral) 2 A (Alpha-Chloralose) 2 A Chlordiazepoxide Librium 2 A Chlorhexadol 2 A Chlormerodrin Neohydrin 4 B Chlormezanone Trancopal 2 A Chloroform 2 A Chlorophenesin Maolate 4 C Chloroprocaine Nesacaine 2 A Chloroquine Avloclor 4 C Chlorothiazide Diuril 4 B Chlorproethazine Newiplege 2 A Chlorpheniramine Chlortriemton, etc. 4 B Thorazine, Largactil 2 A Taractan 2 A Chlorthalidone Hydroton 4 B Chlorzoxazone Paraflex 4 B Ciclesonide 4 B Cilostazol Pletal 5 C Cimeterol 3 A Cimetidine Tagamet 5 D Cinchocaine Nupercaine 4 C Citalopram Celex 2 A Clanobutin 4 B Clemastine Tavist 3 B *Clenbuterol Ventipulmin 3 B Clibucaine Batrax 4 C Clidinium Quarezan, Clindex, etc. 3 B Clobazam Urbanyl 2 A Clobetasol Temovate 4 C 2 A Clocortolone Cloderm 4 C Clofenamide 4 B (Chlormethiazole) 2 A Anafranil 2 A Klonopin 2 A Catapres 3 B Clorazepate Tranxene 2 A

(4/11/16) [Ch. 260-70 WAC p. 13] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Clormecaine Placacid 4 C Clostebol 3 B Clothiapine Entermin 2 A Clotiazepam Trecalmo, Rize 2 A Cloxazolam Enadel, Sepazon, Tolestan 2 A Clozaril, Leponex 2 A a-Cobratoxin 1 A Cocaine 1 B Codeine 1 A Colchicine 4 B Conorphone 2 A Corticaine Ultracain 2 A Cortisone Cortone, etc. 4 C Cromolyn Intel 5 C Crotetamide 2 A Tercian 2 A Cyclandelate Cyclospasmol 3 A Cyclizine Merazine 4 B Phanodorm 2 A Flexeril 4 B Cyclomethylcaine Surfacaine 4 C Cyclothiazide Anyhydron, Renazide 4 B Cycrimine Pagitane 3 B Pericactin 4 C Danazol Danocrine 3 B *Dantrolene Dantrium 4 C Darbepoetin Aranesp 2 A Decamethonium Syncurine 2 A Dehydrochloromethyltestosterone 3 B Dembroxol (Dembrexine) Sputolysin 4 C Demoxepam 2 A Deoxycorticosterone Percortin, DOCA, Descotone, 4 C Dorcostrin Deracoxib Deremaxx 3 B Dermorphin 1 A Norpromine, Pertofrane 2 A Desonite Des Owen 4 C Desoximetasone Topicort 4 C Desoxymethyltestosterone 3 B *Detomidine Dormosedan 3 B *Dexamethasone Axium, etc. 4 C Dextromethorphan 4 B Dextromoramide Palfium, Narcolo 1 A Dextropropoxyphene Darvon 3 B

[Ch. 260-70 WAC p. 14] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Dezocine Dalgan® 2 A Diamorphine 1 A Diazepam Valium 2 B Diazoxide Proglycem 3 B Dibucaine Nupercainal, Cinchocaine 4 C Febenol, Isocom 2 A Dicholorphenamide Daramide 4 C *Diclofenac Voltaren, Voltarol 4 C Dicumarol Dicumarol 5 C Diethylpropion Tepanil, etc. 2 A Diethylthiambutene Themalon 2 A Diflorasone Florone, Maxiflor 4 C Diflucortolone Flu-Cortinest, etc. 4 C Diflunisal 3 B Digitoxin Crystodigin 4 B Digoxin Lanoxin 4 B Dihydrocodeine Parcodin 2 A 4 B Dilorazepam Briantum 2 A Diltiazem Cardizem 4 B Dimefline 3 A Dimethisoquin Quotane 4 B *Dimethylsulfoxide (DMSO) Domoso 4 C Dimethylsulphone (MSM) 5 C Diphenadione 5 C Benadryl 3 B Diphenoxylate Difenoxin, Lomotil 4 B Diprenorphine M50/50 2 A Dipyridamole Persantine 3 B Dipyrone Novin, Methampyrone 4 C Disopyramide Norpace 4 B Divalproex Depakote 3 A Dixyrazine Esucos 2 A Dobutrex 3 B Intropin 2 A Donepezil Aricept 1 A Doxacurium Nuromax 2 A Doxapram Dopram 2 A 3 A Doxans 2 A Adapin, Sinequan 2 A Decapryn 3 B Dromostanolone Drolban 3 B

(4/11/16) [Ch. 260-70 WAC p. 15] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Droperidol Inapsine, Droleptan, Innovar-Vet 2 A (with Fentanyl) Duloxetine 2 A Dyclonine Dyclone 4 C Dyphylline 3 B Edrophonium Tensilon 3 B Elenac 4 B Eletripan Relpax 3 A Eltenac 4 C Enalapril (metabolite enaloprilat) Vasotec 3 B 2 A Endorphins 1 A Enkephalins 1 A 2 A Epibatidine 2 A Epinephrine 2 A mesylates 2 A Ergonovine Ergotrate 4 C Gynergen, Cafegot, etc. 4 B Erthrityl tetranitrate Cardilate 3 A Erythropoietin (EPO) Epogen, Procrit, etc. 2 A Esmolol Brevibloc 3 B Esomeprazole Nexium 5 D Domnamid, Eurodin, Nuctalon 2 A Etamiphylline 3 B Etanercept Enbrel 4 B Ethacrynic Acid Edecrin 3 B Ethamivan 2 A Ethanol 2 A Placidyl 2 A Valmid 2 A Ethoheptazine Zactane 4 B Ethopropazine Parsidol 2 A Ethosuximide Zarontin 3 A Ethotoin Peganone 4 B Ethoxzolamide Cardase, Ehtamide 4 C Ethylaminobenzoate (Benzocaine) Semets, etc. 4 C Ethylestrenol Maxibolin, Organon 3 B Ethylisobutrazine Diquel 2 A Ethylmorphine Dionin 1 A Ethylnorepinephrine Bronkephrine 3 A Etidocaine Duranest 2 A Etifoxin Stresam 2 A Etizolam Depas, Pasaden 2 A

[Ch. 260-70 WAC p. 16] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Etodolac Lodine 3 B Indunox 2 A 2 A Etorphine HCI M99 1 A Famotidine Gaster, etc. 5 D Felbamate Felbatol 3 A Felodipine Plendil 4 B Fenabamate Tymium 2 A Fenbufen Cincopal 3 B Fenclozic Acid Cincopal 2 A Fenfluramine Pondimin 2 A Fenoldopam Corlopam 3 B Fenoprofen Nalfon 3 B Berotec 3 B Respiride, Respan, etc. 3 B Fentanyl Sublimaze 1 A Fentiazac 3 B Fexofenadine Allegra 4 C *Firocoxib 4 C Flecainide Idalon 4 B Floctafenine Idalon, Idarac 4 B Fluanisone Sedalande 2 A Flucinolone Synalar, etc. 4 C Fludiazepam Erispam 2 A Fludrocortisone Alforone, etc. 4 C Flufenamic Acid 3 B Flumethasone Flucort, etc. 4 C Flumethiazide Ademol 4 B Flunarizine Sibelium 4 B Flunisolide Bronilide, etc. 4 C Rohypnol, Narcozep, Darkene, 2 A Hypnodorm Flunixin Banamine 4 C* Fluocinolone Synalar 4 C Flucinonide Licon, Lidex 4 C Fluopromazine Psyquil, Siquil 2 A Fluoresone Caducid 2 A Fluorometholone FML 4 B Fluoroprednisolone Predef-2X 4 C Fluoxetine Prozac 2 A Fluoxymesterone Halotestin 3 B Flupenthixol Depixol, Fluanxol 2 A * Prolixin, Permitil, Anatensol 2 A Flupirtine Katadolone 3 A

(4/11/16) [Ch. 260-70 WAC p. 17] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Fluprednisolone Alphadrol 4 C Flurandrenolide Cordran 4 C Dalmane 2 A Flurbiprofen Froben 3 B Fluspirilene Imap, Redeptin 2 A Fluticasone Flixonase, Flutide 4 C Restas 2 A Fluvoxamine Dumirox, Faverin, etc. 2 A Formebolone 3 B Formeoterol Altram 3 A Fosinopril Monopril 3 A Fosphenytoin Cerebyx 3 B Furazabol 3 B Furosemide Lasix N/A Neurontin 4 B Galantamine Reminyl 2 A Gallamine Flaxedil 2 A 2 A Gestrinone 3 A Doriden 2 A *Glycopryrrolate Robinul 3 B (glycerol guiacolate) Gecolate 4 C Guanadrel Hylorel 3 A Ismelin 3 A Wytensin 3 B Halazepam Paxipam 2 A Halcinonide Halog 4 C Halobetasol Ultravate 4 C Haldol 2 A Somelin 2 A Hemoglobin glutamers Oxyglobin, Hemopure 2 A Heptaminol Corofundol 3 B Heroin 1 A Hexafluorenium Myalexen 2 A Evipal 2 A Hexocyclium Tral 4 C Hexylcaine Cyclaine 4 C Homatropine Homapin 3 B Homophenazine Pelvichthol 2 A Hydralazine Apresoline 3 B Hydrochlorthiazide Hydrodiuril 4 B Hydrocodone Hycodan 1 A (dihydrocodeinone) *Hydrocortisone (Cortisol) Cortef, etc. 4 C

[Ch. 260-70 WAC p. 18] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Hydroflumethiazide Saluron 4 B Hydromorphone Dilaudid 1 A 4-Hydroxtestosterone 3 B Hydroxyamphetamine Paradrine 1 A * Atarax 2 B Ibomal Noctal 2 A Ibuprofen Motrin, Advil, Nuprin, etc. 4 C Ibutilide Corvert 3 B Iloprost Ventavis 3 A Imavate, Presamine, Tofranil 2 A Indomethacin Indocin 3 B Infliximab Remicade 4 B Ipratropium 3 B Irbesaten Avapro 3 A Isapirone 2 A Isocarboxazid Marplan 2 A Isoetharine Bronkosol 3 B *Isoflupredone Predef 4 C Isomethadone 2 A Octin, Octon 4 B Isopropamide Darbid 4 B Isoproterenol Isoprel 2 A Isosorbide dinitrate Isordil 3 B Isoxicam Maxicam 2 A Vasodilan 4 C Isradipine DynaCirc 4 B Kebuzone 3 B Ketalar, Ketaset, Vetalar 2 B Ketazolam Anxon, Laftram, Solatran, Lof- 2 A tran Ketoprofen Orudis 4 C* Ketorolac Toradol 3 A Normodyne 3 B Lamotrigine Lamictal 3 A Lansoprazole 5 D Lenperone Elanone-V 2 A Letosteine Viscotiol, Visiotal 4 C Levamisole 2 B Betagan 3 B Levomethorphan 2 A Levorphanol Levo-Dremoran 1 A *Lidocaine Xylocaine 2 B Lisinopril Prinivil, Zestril 3 A Lithium Lithizine, Duralith, etc. 2 A

(4/11/16) [Ch. 260-70 WAC p. 19] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Lobeline 2 A Lofentanil 1 A Loflazepate, Ethyl Victan 2 A Loperamide Imodium 2 A Dormonort, Havlane 2 A Loratidine Claritin 4 B Ativan 2 A Noctamid 2 A Losartan Hyzaar 3 B Laxitane 3 A 3 A Ludiomil 2 A Mazindol Sanorex 1 A Mebutamate Axiten, Dormate, Capla 2 A Mecamylamine Inversine 3 B Meclizine Antivert, Bonine 4 B Meclofenamic Acid Arquel 4 C Meclofenoxate Lucidiril, etc. 2 A Medazepam Nobrium, etc. 2 A Domitor 3 B Medrysone Medriusar, etc. 4 C Mefenamic Acid Ponstel 3 B Meloxicam Mobic 4 B Eunerpan 2 A Memantine Namenda 2 A Meparfynol Oblivon 2 A Mepazine Pacatal 2 A Mepenzolate Cantil 3 A Meperidine Demerol 1 A Tolserol 4 B Control, etc. 2 A Mephentermine Wyamine 1 A Mephenytoin Mesantoin 2 A Mephobarbital () Mebaral 2 A *Mepivacaine Carbocaine 2 B Equanil, Miltown 2 A Meralluride Mercuhydrin 4 B Merbaphen Novasural 4 B Mercaptomerin Thiomerin 4 B Mercumalilin Cumertilin 4 B Mersalyl Salyrgan 4 B Mesalamine Asacol 5 C Serentil 2 A

[Ch. 260-70 WAC p. 20] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Mestanolone 3 B Mesterolone 3 B Metaclazepam Talis 2 A Metaproterenol Alupent, Metaprel 3 B Aramine 1 A Skelaxin 4 B Metazocine 2 A Metenolone 3 B Methachloline 3 A Methadone Dolophine 1 A Methamphetamine Desoxyn 1 A Methandienone 3 B Methandriol Probolic 3 B Methandrostenolone Dianabol 3 A Methantheline Banthine 3 B Histadyl, etc. 4 B Quaalude 1 A Metharbital Gemonil 2 A Methasterone 3 A Methazolamide Naptazane 4 C Methcathinone 1 A Methdilazine Tacaryl 4 B Methixene Trest 3 A *Methocarbamol Robaxin 4 C Brevital 2 A Methotrexate Folex, Nexate, etc. 4 B Methotrimeprazine Levoprome, Neurocil, etc. 2 A Vasoxyl 3 A Orthoxide 3 A Methscopolamine Pamine 4 B Methsuximide Celontin 3 A Methylatropine 3 B Methyclorthiazide Enduron 4 B Methyldienolone 3 B Aldomet 3 A Methylhexaneamine Geranamine 1 A Methylergonovine Methergine 4 C Methylnortestosterone 3 B Methylphenidate Ritalin 1 A *Methylprednisolone Medrol 4 C Methyltestosterone Metandren 3 A Methyl-1-testosterone 3 A Noludar 2 A

(4/11/16) [Ch. 260-70 WAC p. 21] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Sansert 4 B Metiamide 4 B Metoclopramide Reglan 4 C Metocurine Metubine 2 A Metolazone 3 B Hypnodil 2 A Metopon (methyldihydromorphinone) 1 A Lopressor 3 B Mexazolam Melex 2 A Mexilitine Mexilil 4 B Mibefradil Posicor 3 B Mibolerone 3 B Versad 2 A Pro-Amiline 3 B Milrinone 4 B Minoxidil Loniten 3 B Remeron 2 A Misoprostel Cytotec 5 C Mivacurium Mivacron 2 A Modafinil Provigil 2 A Moexipril (metabolite moexiprilat) Uniretic 3 B Molindone Moban 2 A Mometasone Elocon 4 C Montelukast Singulair 4 C Moperone Luvatren 2 A Morphine 1 B Mosaprimine 2 A Muscarine 3 A Myo-Inositol Trispyrophospahte (ITPP) 1 A Nabumetone Anthraxan, Relafen, Reflifex 3 A Nadol Corgard 3 B Naepaine Amylsine 4 C Nalbuphine Nubain 2 A Nalorphine Nalline, Lethidrone 2 A Naloxone Narcan 3 A Naltrexone Revia 3 A *Nandrolone Nandrolin, Laurabolin, Dura- 3 B bolin Privine 4 B Naproxen Equiproxen, Naprosyn 4 C Naratriptan Amerge 3 B 3 A Nedocromil Tilade 5 C Serzone 2 A

[Ch. 260-70 WAC p. 22] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Nefopam 3 A Neostigmine Prostigmine 3 B Nicardipine Cardine 4 B Nifedipine Procardia 4 B Niflumic Acid Nifluril 3 B Nikethamide Coramine 1 A Nimesulide 3 B Erimin 2 A Nimodipine Nemotop 4 B Mogadon 2 A Nitroglycerin 3 B Nizatidine Axid 5 C 19-Norandrostenediol 3 B 19-Norandrostenedione 3 B Norbolethone 3 B Norclostebol 3 B Nordiazepam Calmday, Nordaaz, etc. 2 A 2 A Norethandrolone 3 A Nortestosterone 4 C Nortiptyline Aventyl, Pamelor 2 A Nylidrine Arlidin 3 A Olanzepine Zyprexa 2 A Olmesartan Benicar 3 A Olsalazine Dipentum 4 B Omeprozole Prilosec, Losec 5 D Orphenadrine Norlfex 4 B Oxabolone 3 B Oxandrolone Anavar 3 B Oxaprozin Daypro, Deflam 4 C Oxazepam Serax 2 A Oxazolam Serenal 2 A Oxcarbazepine Trileptal 3 A (hydroxyephedrine) 2 A Trasicor 3 B Oxycodone Percodan 1 A Oxymesterone 3 B Afrin 4 B Oxymetholone Adroyd, Anadrol 3 B Oxymorphone Numorphan 1 A Oxyperitine Forit, Integrin 2 A Oxyphenbutazone Tandearil 4 C Oxyphencyclimine Daricon 4 B

(4/11/16) [Ch. 260-70 WAC p. 23] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Oxyphenonium Antrenyl 4 B 2 A Pancuronium Pavulon 2 A Pantoprazole Protonix 5 D Papaverine Pavagen, etc. 3 A Paral 2 A Paramethadione Paradione 3 A Paramethasone Haldrone 4 C Pargyline Eutonyl 3 A Paroxetine Paxil, Seroxat 2 A Pemoline Cylert 1 A Levatol 3 B Penfluridol Cyperon 2 A Pentareythritol tetranitrate Duotrate 3 A Pentazocine Talwin 3 B Nembutal 2 A Pentoxyfylline Trental, Vazofirin 4 C Pentylenetetrazol Metrazol, Nioric 1 A Taxilan 2 A Perflurodecolin 2 A Perfluorodecahydronophthalene 2 A Perfluorooctylbromide 2 A Perfluorotripropylamine 2 A Perfluorocarbons 2 A Permax 3 B Pericianzine Alodept, etc. 2 A Perindopril Biprel 3 A Hypnodin 2 A Trilafon 2 A Phenacemide Phenurone 4 B Acalo, Alcamid, etc. 2 A Phenazocine Narphen 1 A Phencyclidine (PCP) Sernylan 1 A Phendimetrazine Bontril, etc. 1 A Phenelzine Nardelzine, Nardil 2 A Phenindione Hedulin 5 C Phenmetrazine Preludin 1 A Luminal 2 A Dibenzyline 3 B Phenprocoumon Liquamar 5 C Phensuximide Milontin 4 B Phentermine Iomamin 2 A Regitine 3 B

[Ch. 260-70 WAC p. 24] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class *Phenylbutazone Butazolidin 4 C Isophrin, Neo- 3 B Propadrine 3 B Phenytoin Dilantin 4 B Physostigmine Eserine 3 B Picrotoxin 1 A Piminodine Alvodine, Cimadon 2 A Pimozide Orap 2 A Pinazepam Domar 2 A Viskin 3 A Dipiperon 2 A Pipecuronium Arduan 2 A Pipequaline 2 A Piperacetazine Psymod, Quide 2 A Piperocaine Metycaine 2 A Lonseren, Piportil 2 A Pipradrol Datril, Gerondyl, etc. 2 A Piquindone 2 A Maxair 3 A Pirenzapine Gastrozepin 5 C Piretanide Arelix, Tauliz 3 B Piritramide 1 A Piroxicam Feldene 3 B Polyethylene glycol 5 C Polythiazide Renese 4 B Pramoxine Tronothaine 4 C Prazepam Verstran, Centrax 2 A Minipress 3 B *Prednisolone Delta-Cortef, etc. 4 C Prednisone Meticorten, etc. 4 C Prilocaine Citanest 2 C Primidone Mysoline 3 B Probenecid 4 C Procainamide Pronestyl 4 B *Procaine 3 B Pro Air 3 A Darbazine, Compazine 2 A Procyclidine Kemadrin 3 B *Promazine Sparine 3 B Phenergan 3 B Rythmol 4 B Propanidid 2 A Propantheline Pro-Banthine 3 A

(4/11/16) [Ch. 260-70 WAC p. 25] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Proparacaine Ophthaine 4 C Propentophylline Karsivan 3 B Largon 2 A Propionylpromazine Tranvet 2 A Propiram 2 A Diprivan, Disoprivan 2 A Propoxycaine Ravocaine 2 A Inderal 3 B Propylhexedrine Benzedrex 4 B Prostanazol 3 B Prothipendyl Dominal 2 A Protolylol Ventaire 3 A Concordin, Triptil 2 A Axeen, Centralgol 2 A Cenafed, Novafed 3 B Pryidostigmine Mestinon, Regonol 3 B *Pyrilamine Neoantergan, Equihist 3 B Hybersulfan, Sonodor 2 A Quazipam Doral 2 A Seroquel 2 A Quinapril, Quinaprilat Accupril 3 A Quinbolone 3 B Quinidex, Quinicardine 4 B Rabeprazole Aciphex 5 D Racemethorphan 2 A Racemorphan 2 A Raclopride 2 A Raylean 3 A Ramipril, metabolite Ramiprilat Altace 3 A Rantidine Zantac 5 D Remifentanil Ultiva 1 A Remoxipride Roxiam 2 A Reserpine Serpasil 2 A Rilmazafone 2 A 2 A 2 A Yutopar 3 B Rivastigmine Exelon 3 B Rizatriptan Maxalt 3 B Rocuronium Zemuron 2 A Rofecoxib Vioxx 2 A Sedivet 2 B Ropivacaine Naropin 2 A

[Ch. 260-70 WAC p. 26] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Salicylamide 4 C *Salicylates 4 C 3 B (Hyoscine) Triptone 3 B (Quinalbarbitone) Seconal 2 A Selegiline Eldepryl, Jumex 2 A Sertraline Lustral, Zoloft 2 A Sibutramine Meridia 3 B Sildenafil Viagra 3 A Snake Venoms 2 A Somatrem Protropon 2 A Somatropin Nutropin 2 A Betapace, Sotacor 3 B Spiclomazine 2 A 2 A Spirapril, metabolite Spiraprilat Renomax 3 A Spironalactone Aldactone 4 B Stanozolol Winstrol-V 3 B Stenbolone 3 B Strychine 1 B Succinylcholine Sucostrin, Quelin, etc. 2 A Sufentanil Sufenta 1 A Sulfasalazine Axulfidine, Azaline 4 C Sulfondiethylmethane 2 A 2 A Inofal 2 A Sulindac Clinoril 3 A Sulpiride Aiglonyl, Sulpitil 2 A Sultopride Barnetil 2 A Sumatriptan Imitrex 3 B Synthetic Spice, K2, Kronic 1 A Tadalasil Cialis 3 A Talbutal Lotusate 2 A 2 A Telmisartin Micardis 3 B Restoril 2 A Tenoxicam Alganex, etc. 3 B Tepoxalin 3 B Hytrin 3 A Brethine, Bricanyl 3 B Terfenadine Seldan, Triludan 4 B Testolactone Teslac 3 B *Testosterone 3 B

(4/11/16) [Ch. 260-70 WAC p. 27] 260-70-685 Equine Medication Program

Drug Trade Name Class Penalty Class Tetrabenzaine Nitoman 2 A Tetracaine Pontocaine 2 A Tetrahydrogestrinone 3 A Tetrahydrozoline Tyzine 4 B Tetrazepam Musaril, Myolastin 2 A Thebaine 2 A Theobromine 4 B Theophylline Aqualphyllin, etc. 3 B Kemithal 2 A Surital 2 A Thiethylperazine Torecan 2 A Thiopental Pentothal 2 A Dartal 2 A Thiorpoperazine Mejeptil 2 A Mellaril 2 A Thiosalicylate 4 C Thiothixene Navane 2 A Thiphenamil Trocinate 4 B Tiapride Italprid, Luxoben, etc. 2 A Tiaprofenic Acid Surgam 3 B Tiletamine Component of Telazol 2 A Timiperone Tolopelon 2 A Blocardrin 3 B Tocainide Tonocard 4 B Tofisopam Grandaxain, Seriel 2 A Priscoline 3 B Tolmetin Tolectin 3 B Topirimate Topamax 2 A Torsemide (Torasemide) Demadex 3 A Tramadol Ultram 2 A Trandolapril (and metabolite, Trandolaprilat) Tarka 3 B Tranexamic Acid 4 C Tranylcypromine Parnatet 2 A Trazonde Desyrel 2 A Trenbolone Finoplix 3 B Inolin 2 A *Triamcinolone Vetalog, etc. 4 C Triamterene Dyrenium 4 B Halcion 2 A Tribromethanol 2 A Tricaine methanesulfonate Finquel 2 A Trichlormethiazide Naqua, Naquasone 4 C Trichloroethanol 2 A

[Ch. 260-70 WAC p. 28] (4/11/16) Equine Medication Program 260-70-685

Drug Trade Name Class Penalty Class Tricholoethylene Trilene, Trimar 2 A Triclos 2 A Tridihexethyl Pathilon 4 B Trifluomeprazine Nortran 2 A Stelazine 2 A Trifluperidol Triperidol 2 A Vetame, Vesprin 2 A Trihexylphenidyl Artane 3 A Trimeprazine Temaril 4 B Trimethadione Tridione 3 B Trimethaphan Arfonad 3 A Surmontil 2 A Tripelennamine PBZ 3 B Triprolidine Actidil 4 B Tubocurarine (Curare) Metubin 2 A Benvil, Nospan, etc. 2 A Urethane 2 A Valdecoxib 2 A 3 A Nirvanyl 2 A Valsartan Diovan 3 B Vardenafil Levitra 3 A Vedaprofen 4 B Venlafaxine Effexor 2 A Veralipride Accional, Veralipril 2 A Verapamil Calan, Isoptin 4 B Vercuronium Norcuron 2 A Viloxazine Catatrol, Vivalan, etc. 2 A Delvinol 2 A Optanox, Speda 2 A Warfarin Coumadin, Coufarin 5 C *Xylazine Rompun, Bay VA 1470 3 B Otrivin 4 B 2 A Zafirlukast Accolate 4 C Sonata 2 A Zeranol Ralgro 4 C Ziconotide 1 A Zileuton Zyflo 4 C hydrochloride 3 A Geodon 2 A Zolazepam 2 A Zolmitriptan Zomig 3 B

(4/11/16) [Ch. 260-70 WAC p. 29] 260-70-710 Equine Medication Program

Drug Trade Name Class Penalty Class Ambien, Stilnox 2 A Zomepirac Zomax 2 A Zonisamide Zonegran 3 B Imovan 2 A Lodopin 2 A Ciatyl, Cesordinol 2 A Δ-1-androstene-3, 17-diol 3 A Δ-1-androstene-3, 17-dione 3 A Δ-1-dihydrotestosterone 3 A [Statutory Authority: RCW 67.16.020. WSR 15-07-058, § 260-70-685, filed 3/16/15, effective 4/16/15; WSR 12-07-006, § 260-70-685, filed 3/9/12, effective 4/9/12.]

WAC260-70-710 260-70-710 Voiding track record. In the event expires or is destroyed, or any horse that expires while that a horse establishes a track record in a race and if it later housed on the grounds. In proceeding with a postmortem develops that the chemical analysis of any sample taken indi- examination the commission or its designee will coordinate cates the presence of any prohibited substances for which the with the trainer and/or owner to determine and address any purse is redistributed, then such track record shall be null and insurance requirements. void. (2) Trainers and owners must cooperate with such action [Statutory Authority: RCW 67.16.040. WSR 96-10-001, § 260-70-710, filed as a condition of licensure. 4/17/96, effective 5/18/96.] (3) An official veterinarian may take possession of the horse upon death for postmortem examination. An official WAC260-70-720 260-70-720 Posterior digital neurectomy. (1) veterinarian may submit blood, urine, other bodily fluid spec- No person may bring onto the grounds of a racing associa- imens or other tissue specimens collected during a postmor- tion, or enter or cause to be entered in any race, or sell, offer tem examination for analysis. Upon completion of the post- for sale, or act as an agent in the sale of any horse on the mortem examination, the remains may be returned to the grounds under the jurisdiction of the commission that has had owner or disposed of at the owner's option. a posterior digital neurectomy performed, or has had any (4) The presence of a prohibited substance in a specimen nerve removed from the leg of such horse, except as provided collected during the postmortem examination may constitute in this chapter. a violation of these rules. (2) A horse upon which a posterior digital neurectomy (5) The cost of commission-ordered postmortem exam- has been performed is eligible to race if the following condi- inations, testing and disposal will be borne by the commis- tions are met: sion. (a) Prior approval of an official veterinarian has been [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § obtained before the horse was brought onto the grounds of the 260-70-730, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- racing association; 730, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-730, filed (b) An official veterinarian is satisfied that the loss of 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- sensation to the horse due to the posterior digital neurectomy 10-001, § 260-70-730, filed 4/17/96, effective 5/18/96.] will not endanger the safety of the public and the participants in racing and does not compromise the integrity of horse rac- ing; (c) The racing secretary is notified of the posterior digital neurectomy at the time the horse is admitted to the grounds of the racing association; and (d) The horse's registration or eligibility certificate has been marked to indicate that a posterior digital neurectomy was performed. [Statutory Authority: RCW 67.16.020 and 67.16.040. WSR 07-07-036, § 260-70-720, filed 3/12/07, effective 4/12/07; WSR 06-09-009, § 260-70- 720, filed 4/10/06, effective 5/11/06; WSR 05-07-067, § 260-70-720, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. WSR 96- 10-001, § 260-70-720, filed 4/17/96, effective 5/18/96.]

WAC260-70-730 260-70-730 Postmortem examination. (1) The commission may require a postmortem examination of any horse that is injured on the grounds of a racing association during its scheduled race meet and training periods, while the horse is in training or in competition and that subsequently [Ch. 260-70 WAC p. 30] (4/11/16)